Alder Therapeutics AB

https://www.aldertx.com

LinkedIn: https://www.linkedin.com/company/alder-therapeutics

Alder Therapeutics is a biotechnology company on a mission to cure the incurable by harnessing the potential of pluripotent stem cell-developed therapies. Through our unique cell therapy development philosophy, we overcome the challenges of traditional development approaches, embedding risk reduction and commercial-mindedness at the core of cell therapy programs. We have two promising allogenic stem cell therapies in the pipeline, both with pre-clinical proof of concept data. Our flagship program is a retinal cell therapy aiming to revolutionize treatment of Retinitis Pigmentosa. *

	Start	2024-02-20 existent
	Industry	cell therapy
	Person	Tryggvason, Kristian (Alder Therapeutics 202402 CEO formerly BioLamina 201303 CEO)

	Region	Solna
	Country	Sweden
	Street	4 Nanna Svartz Väg
	City	12165 Solna
	Tel	+46-70-743-2233
		Address record changed: 2024-02-20

Basic data	Employees	n. a.

		* Document for »About Section«: FyoniBio GmbH. (2/7/24). "Press Release: FyoniBio Collaborates with BioLamina and Alder Therapeutics". Berlin.

		Record changed: 2024-02-20

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for Alder Therapeutics AB

[1] FyoniBio GmbH. (2/7/24). "Press Release: FyoniBio Collaborates with BioLamina and Alder Therapeutics". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)